What Happens When Two Treatments Join Forces Against Liver Cancer
Think about liver cancer, or hepatocellular carcinoma (HCC), it's a tough opponent. But what if we could team up two powerful treatments to fight it? That's exactly what a recent study did. They combined transarterial chemoembolization (TACE) with lenvatinib, a targeted therapy. The results? A signi